Physio-Control And FDA Agree On Plan To Address Quality System Issues
   
 
Home | Support
 
Headline News:
FDA
Fake Drugs
Drug Testing
 
 
Physio-Control And FDA Agree On Plan To Address Quality System Issues
29 Apr 08, 12:09
Physio-Control, Inc., a wholly-owned subsidiary of Medtronic, Inc., (NYSE: MDT) announced that it has reached an agreement on a consent decree with the U.S. Food and Drug Administration (FDA) regarding its quality system improvements for its external defibrillator products. The agreement was filed on Friday, April 25, in the U.S.
more

 

 
© 2007 nafdacnigeria.org